Albany – NY, Oct. 20, 2015 (GLOBE NEWSWIRE) — According to a new market report published by Transparency Market Research “Peptide Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” the global peptide therapeutics market was valued at USD 18.9 billion in 2013 and is estimated to reach USD 23.7 billion by 2020 at a CAGR of 2.8% from 2014 to 2020.
Browse Market Research Report on Global Peptide Therapeutics Market: http://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Therapeutic peptides have been approved for various indications including metabolic disorders, hematological disorders, cancer, cardiovascular disorders, central nervous system disorders, infection, gastrointestinal disorders, respiratory disorders, acromegaly, and others. Such diverse areas of application dictate efficiency of peptides in medical treatment. Increasing research and development activities towards exploration of novel peptides with better therapeutic effect has resulted in a rich pipeline. Animal sources such as venom have been major sources of peptides for research. Scientists are also trying various microbial sources for discovery of novel peptides with therapeutic effect. Despite extensive research efforts, oral delivery of therapeutic peptides or proteins is still a challenge for researchers, due to unfavorable physiological conditions such as acidic pH and presence of proteolytic enzymes. Moreover, low permeability of peptides across the intestinal barrier is a factor adding to the low bioavailability.
Since 2001, over 19 new therapeutic peptides have been approved in the U.S., of these eight were approved in 2012, according to a review article published in the Drug Discovery Today. While new peptide drugs receive regulatory clearance, several peptide drugs are also expected to go off-patent during the forecast period. Generic manufacturers face difficulties in drug approval, as biologics are hard to mimic. Increased costs have driven players to quit research and development activities. This is also a reason why generic peptide drugs retain over 70% to 80% of the branded drug’s price. Due to such high price of generic drugs, peptide therapeutics market is expected to grow rapidly post approval of generic versions. Generic leuprolide is marketed under brand names Enantone, Eligard, and Lupron; of which Enantone and Lupron recorded sales of more than USD 800 million globally.
Get Sample Report Copy of Peptide Therapeutics Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418
Currently, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Novo Nordisk account for over 50% of the global peptide therapeutics market share. Patent expiry of Copaxone in 2014, and Velcade in 2017 and expected launch of their generic alternatives may alter the market trend. Other key players in the market include AstraZeneca plc, Novartis International AG, Eli Lilly & Co., AbbVie, Inc. and Merck & Co.
Browse Upcoming Market Research Reports:
Electronic Medical Records Market: http://www.transparencymarketresearch.com/electronic-medical-records-market.html
Extracorporeal Shock Wave Lithotripsy Market: http://www.transparencymarketresearch.com/extracorporeal-shock-wave-lithotripsy-market.html
The global peptide therapeutics market has been segmented as below:
Global Peptide Therapeutics Market, by Application
- Zoladex (goserelin)
- Velcade (bortezomib)
- Lupron/ Enantone/ Eligard (leuprorelin)
- Angiomax (bivalirudin)
- Integrilin (eptifibatide)
Central Nervous System
- Copaxone (glatiramer)
- Victoza (liraglutide)
- Byetta (exenatide)
- Incivek (telaprevir)
- Victrelis (boceprevir)
- Firazyr (icatibant)
- Kalbitor (ecallantide)
- Gattex (teduglutide)
- Linzess (linaclotide)
Global Peptide Therapeutics Market, by Route of Administration
Global Peptide Therapeutics Market, by Marketing Status
Global Peptide Therapeutics Market, by Geography
- North America
- Asia Pacific
- Rest of the World
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
CONTACT: Mr. Nachiket Ghumare State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: firstname.lastname@example.org Website: http://www.transparencymarketresearch.com